Roland Boivin
Chief Executive Officer at GENETETHER THERAPEUTICS INC.
Net worth: 6 075 $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
R. Geoffrey Sargent | M | 70 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 years |
Daren Graham | M | 52 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 years |
Garner William | M | 58 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 years |
Michael Mueller | M | 64 | 10 years | |
Richard Labelle | M | - | 10 years | |
Philip Jull | M | 64 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 years |
Andre Pereira Fraga Figueiredo | M | 48 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 years |
Jean Jen | F | 37 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 years |
Adele Gulfo | F | 61 | 5 years | |
Nathalie Laurin | F | 55 | 11 years | |
Benoit Gravel | M | - | 7 years | |
Kenneth d’Entremont | M | - | 6 years | |
Stephen Nelson | M | - | 6 years | |
Marcel Konrad | M | 49 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sylvain Chrétien | M | 59 | 11 years | |
Peter van der Velden | M | 62 | 5 years | |
Normand Chartrand | M | 64 | 5 years | |
Pierre LaPalme | M | 83 | 5 years | |
Douglas Murray Stuve | M | 56 | - | |
Pierre Désormeau | M | 71 | 4 years | |
Roy Millington | M | 64 | - | |
Larry Edward Hoover | M | 67 | 3 years | |
Arvind Jain | M | 77 | 2 years | |
Ashok Bhaseen | M | 66 | 2 years | |
Angelo S. Botter | M | 76 | 1 years | |
Mary Shoemaker | F | 63 | - | |
Benoît Hébert | M | 56 | 6 years | |
Michael Pine | M | - | - | |
Peter Sampson | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 29 | 100.00% |
United States | 6 | 20.69% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roland Boivin
- Personal Network